J&J Pharma Chief Eyes Icotyde Cross-Indication Expansion
Johnson & Johnson's incoming pharmaceutical chief told Fierce Pharma the company expects Icotyde's psoriasis launch momentum to repeat across additional indications, framing the drug as a multi-disea…